IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 189 filers reported holding IMMUNOGEN INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,626,397 | +30.9% | 1,173,686 | +55.6% | 0.44% | +42.0% |
| Q2 2023 | $14,234,603 | +17303.4% | 754,351 | +3441.6% | 0.31% | +15500.0% |
| Q1 2023 | $81,792 | -96.7% | 21,300 | -95.7% | 0.00% | -96.5% |
| Q4 2022 | $2,473,552 | -18.3% | 498,700 | -6.6% | 0.06% | -32.1% |
| Q3 2021 | $3,027,000 | +2487.2% | 534,000 | +2001.5% | 0.08% | +950.0% |
| Q2 2020 | $117,000 | +41.0% | 25,410 | +5.0% | 0.01% | +14.3% |
| Q1 2020 | $83,000 | +6.4% | 24,200 | -33.0% | 0.01% | 0.0% |
| Q2 2019 | $78,000 | -2.5% | 36,095 | +22.9% | 0.01% | -12.5% |
| Q1 2019 | $80,000 | – | 29,370 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |